HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Halocynthiaxanthin and peridinin sensitize colon cancer cell lines to tumor necrosis factor-related apoptosis-inducing ligand.

Abstract
Carotenoids are compounds contained in foods and possess anticarcinogenic activity. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising candidate for cancer therapeutics due to its ability to induce apoptosis selectively in cancer cells. However, some tumors remain tolerant to TRAIL-induced apoptosis. Therefore, it is important to develop agents that overcome this resistance. We show, for the first time, that certain carotenoids sensitize cancer cells to TRAIL-induced apoptosis. Combined treatment with halocynthiaxanthin, a dietary carotenoid contained in oysters and sea squirts, and TRAIL drastically induced apoptosis in colon cancer DLD-1 cells, whereas each agent alone only slightly induced apoptosis. The combination induced nuclear condensation and poly(ADP-ribose) polymerase cleavage, which are major features of apoptosis. Various caspase inhibitors could attenuate the apoptosis induced by this combination. Furthermore, the dominant-negative form of a TRAIL receptor could block the apoptosis, suggesting that halocynthiaxanthin specifically facilitated the TRAIL signaling pathway. To examine the molecular mechanism of the synergistic effect of the combined treatment, we did an RNase protection assay. Halocynthiaxanthin markedly up-regulated a TRAIL receptor, death receptor 5 (DR5), among the death receptor-related genes, suggesting a possible mechanism for the combined effects. Moreover, we examined whether other carotenoids also possess the same effects. Peridinin, but not alloxanthin, diadinochrome, and pyrrhoxanthin, induced DR5 expression and sensitized DLD-1 cells to TRAIL-induced apoptosis. These results indicate that the combination of certain carotenoids and TRAIL is a new strategy to overcome TRAIL resistance in cancer cells.
AuthorsTatsushi Yoshida, Takashi Maoka, Swadesh K Das, Kazuki Kanazawa, Mano Horinaka, Miki Wakada, Yoshiko Satomi, Hoyoku Nishino, Toshiyuki Sakai
JournalMolecular cancer research : MCR (Mol Cancer Res) Vol. 5 Issue 6 Pg. 615-25 (Jun 2007) ISSN: 1541-7786 [Print] United States
PMID17579120 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Caspase Inhibitors
  • Enzyme Inhibitors
  • TNF-Related Apoptosis-Inducing Ligand
  • Xanthophylls
  • pyrrhoxanthin
  • peridinin
  • Carotenoids
  • halocynthiaxanthin
  • Poly(ADP-ribose) Polymerases
  • alloxanthin
  • 4-Butyrolactone
Topics
  • 4-Butyrolactone (analogs & derivatives, pharmacology)
  • Apoptosis
  • Carotenoids (metabolism, pharmacology)
  • Caspase Inhibitors
  • Cell Line, Tumor
  • Colonic Neoplasms (drug therapy)
  • Enzyme Inhibitors (pharmacology)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Signal Transduction
  • TNF-Related Apoptosis-Inducing Ligand (metabolism)
  • Xanthophylls (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: